A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)
Clinical trial NCT04245839 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04245839
- Sponsor
- Celgene
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-14
- Primary completion
- 2031-09-30
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.